Evernorth Holdings Registered 91.6% of Its Equity for Resale — and Its XRP Treasury Still Trades at 1.9x Its Tokens

Search \"Evernorth\" expecting a pharmacy middleman and you land on a single-asset crypto vehicle. Evernorth Holdings is a Nevada corporation whose only business is holding XRP; it closed its merger with a SPAC on October 9, 2026 and began trading on Nasdaq on October 12 as XRPN. It has no revenue and no operating business, and the last balance sheet it has published, at June 30, 2026, shows stockholders' equity of negative $14.5 million. The SEC itself classifies the registrant under commodity contracts brokers and dealers, the crypto-assets desk. The Cigna Group, whose Evernorth Health Services segment is the pharmacy and care-services business, reported $274.9 billion of revenue and $6.0 billion of net income for 2025. Nothing in the October 30 filing touches that business.

Three mechanics explain the size. The registration covers every economic interest in the company except the 6,992,045 Class A shares their holders did not put up for sale, so it covers ten and a half times the Class A their holders did not put up for sale. Seventy-four percent of the block is Class C and Company Unit paper that converts or redeems into Class A first, and the prospectus flags the risk of issuing shares to satisfy those redemptions in plain language. And the sponsor warrants are the only piece that creates new stock: 239,653 warrants exercisable at $11.50, redeemable for a penny each once the shares reach $18.00, and listed separately on Nasdaq as XRPNW.

Every share and unit in the merger was priced at $10.00, and each one was sized by the same formula: the subscriber's XRP, valued at the $2.36609 signing price, divided by $10.00, then multiplied by the closing price over the signing price. The closing price was $1.43069, the three-day average of the CME CF XRP-Dollar Reference Rate. A 39.5% fall in the token therefore produced 39.5% fewer shares for the same XRP, and the gap landed on the contributors rather than on the price: $918.3 million of XRP delivered at the signing price produced $555.3 million of equity.

The accounting makes the valuation harder to read, not easier. The prospectus states that Evernorth's XRP does not meet the scoping criteria of ASC 350-60-15-1f and continues to be carried as an indefinite-lived intangible under ASC 350-30, at historical cost less accumulated impairment. That is why the pro forma balance sheet at June 30, 2026 shows about $349 million of digital assets inside $425.2 million of total assets and $153.2 million of stockholders' equity. Book value therefore tells you nothing about the treasury, and price-to-book is meaningless for this issuer at negative $0.63 per share. The Bitcoin and Ether treasury names below trade at 0.76 to 1.00 times book, multiples that only make sense if the coins behind them are marked close to market. Evernorth's multiple of its own tokens has no counterpart in the group.

Upstream, the closing price that fixed the share count came from CME's benchmark — the $1.43069 three-day average of the CME CF XRP-Dollar Reference Rate, the same rate family CME uses to settle its listed XRP futures and options. Downstream, the demand for the token does not come from the treasury stock. On October 14 the company named Ripple, Kraken, Coinbase and BitGo as the execution partners that will start deploying the 473 million token treasury in the fourth quarter, and it hired Hugo Jeandesboz, formerly co-chief investment officer of Coinbase Asset Management, to run the program. Meanwhile Canary XRP ETF offers the same token to investors who want daily liquidity instead of a six-month lock-up.

For investors who want XRP exposure, a cheaper and cleaner wrapper sits next to this one. Canary XRP ETF offers a cheaper and cleaner route to the same token — daily liquidity, a daily fair-value net asset value, a 0.50% expense ratio and no lock-up — while Evernorth Holdings offers a 1.93 times premium to the tokens, a cost-basis balance sheet that hides the decline from earnings, a 91.6% registered overhang and a treasury that has to start selling in the fourth quarter. The resale registration is not the catalyst. It is the receipt: it tells you who holds the stock, how much of it is contractually frozen until April 2027, and how thin the market is that has to absorb it.